The Life Saving Drugs Program (LSDP) Expert Panel considers all applications to list new medicines on the LSDP. The Panel assesses applications for medicines to be added to the LSDP and advises the Chief Medical Officer. It also reviews medicines already on the program.
Type of Body
D. Advisory Body - Policy and Stakeholder Consultation
Established By / Under
Principal Body / Management Board / Senior Executive Officer
Max No. of Board/Committee Members
Annual Report Prepared and tabled?
Current board appointments
|Position||Appointee||Start Date||End Date|
|Chair||Prof. Andrew Roberts||1 May 2022||30 April 2024|
|Member||Prof. Rosalie Viney||1 December 2022||30 November 2025|
|Member||Ms. Nicole Millis||1 December 2022||30 November 2024|
|Member||Prof. Jonathan Craig||17 December 2021||17 December 2023|
|Member||Ms. Liliana Bulfone||17 December 2021||17 December 2023|
|Member||Prof. John Christodoulou||1 December 2022||30 November 2024|